Midgard Science

Labs / Assays & in vitro testing

Receptor

London, United Kingdom · receptor.ai

Receptor.AI develops AI-driven drug discovery platforms for therapeutic molecule design. It works on small molecules, peptides, and biologics/proximity modalities for drug discovery projects and co-development programs, with headquarters in London and operations linked to Central Europe and the US.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Small Molecules Platform

    AI drug discovery workflows for target classes such as kinases, GPCRs, ion channels, and enzymes, including pocket identification, SAR analysis, virtual screening, selectivity optimization, and ADMET prediction.

  • Peptide Platform

    De novo design of peptides and binders, including orally bioavailable peptides, with optimization of activity, permeability, and oral availability.

  • Biologics & Proximity Platform

    Design of proximity inducers and antibody-enabled therapeutics, including degraders, molecular glues, PPI disruptors, bispecifics, and immune cell engagers.

  • End-to-end peptide discovery platform

    Therapeutic peptide discovery from hit identification to drug candidates, with orchestration across the peptide DMTA cycle and software access.

  • Co-development programs

    Co-development projects progressing from hit discovery to preclinical stage for selected therapeutic targets.

  • Platform access

    SaaS access to the drug discovery platform for target-to-lead workflows.

  • Drug design consultancy

    Consultancy on drug discovery and platform-based molecular design projects.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC, Peptide, Recombinant protein
Assays and studies
SAR analysis, virtual screening, ADMET prediction, protein-ligand preparation, PPI structure prediction, ternary complex prediction
Therapeutic areas
nephrology, oncology, inflammation, cardiology
What to send
target sequence or available 3D structure · request details via contact form
Sites
Kyiv, Ukraine · London, United Kingdom · Central Europe
Team
15 experts
Serves
Japan
Address
2024 Expanded Scientific Leadership Dr. Rajiah Aldrin Denny joined as Chief Scientific Advisor. Dr. Tomi K
Founded
2021

Public records

Ownership
Receptor Holding ApS · DK GLEIF

Similar labs. Aurigene Pharmaceutical Services, Sparx BIO, Sai Life, Evotec

Found in a contract services directory. Listing built from receptor.ai. Work here? Claim this listing.

Receptor · Midgard Science